270
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Specific Targeting and Noninvasive Imaging of Breast Cancer Stem Cells Using Single-Walled Carbon Nanotubes as Novel Multimodality Nanoprobes

, , , &
Pages 31-46 | Received 19 May 2015, Accepted 30 May 2015, Published online: 24 Nov 2015

References

  • Desantis C , MaJ , BryanL , JemalA . Breast cancer statistics, 2013 . CA Cancer J. Clin.64 ( 1 ), 52 – 62 ( 2014 ).
  • Weigelt B , PeterseJL , Van ‘T VeerLJ . Breast cancer metastasis: markers and models . Nat. Rev. Cancer5 ( 8 ), 591 – 602 ( 2005 ).
  • Siegel R , NaishadhamD , JemalA . Cancer statistics, 2013 . CA Cancer J. Clin.63 ( 1 ), 11 – 30 ( 2013 ).
  • Sultana Shaik A , DasG , Al FarajA . Nanomedicine: A Targeted Combat Against Cancer Stem Cells?LAP Lambert Academic Publishing, GmbH KG , Saarbrücken, Germany ( 2015 ).
  • Al-Hajj M , WichaMS , Benito-HernandezA , MorrisonSJ , ClarkeMF . Prospective identification of tumorigenic breast cancer cells . Proc. Natl Acad. Sci. USA100 ( 7 ), 3983 – 3988 ( 2003 ).
  • Mannello F . Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm . BMC Med.11 , 169 ( 2013 ).
  • Dean M , FojoT , BatesS . Tumour stem cells and drug resistance . Nat. Rev. Cancer5 ( 4 ), 275 – 284 ( 2005 ).
  • Diehn M , ClarkeMF . Cancer stem cells and radiotherapy: new insights into tumor radioresistance . J. Natl Cancer Inst.98 ( 24 ), 1755 – 1757 ( 2006 ).
  • Chen K , HuangYH , ChenJL . Understanding and targeting cancer stem cells: therapeutic implications and challenges . Acta Pharmacol. Sin.34 ( 6 ), 732 – 740 ( 2013 ).
  • Charafe-Jauffret E , GinestierC , IovinoFet al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature . Cancer Res.69 ( 4 ), 1302 – 1313 ( 2009 ).
  • Fang J-Y , Al-SuwayehSA . Nanoparticles as delivery carriers for anticancer prodrugs . Expert Opin. Drug Deliv.9 ( 6 ), 657 – 669 ( 2012 ).
  • Bertrand N , WuJ , XuX , KamalyN , FarokhzadOC . Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology . Adv. Drug Deliv. Rev.66 , 2 – 25 ( 2014 ).
  • Ji S-R , LiuC , ZhangBet al. Carbon nanotubes in cancer diagnosis and therapy . Biochim. Biophys. Acta1806 ( 1 ), 29 – 35 ( 2010 ).
  • Gong H , PengR , LiuZ . Carbon nanotubes for biomedical imaging: the recent advances . Adv. Drug Deliv. Rev.65 ( 15 ), 1951 – 1963 ( 2013 ).
  • Rastogi V , YadavP , BhattacharyaSSet al. Carbon nanotubes: an emerging drug carrier for targeting cancer cells . J. Drug Deliv. doi:10.1155/2014/670815 ( 2014 ) ( Epub ahead of print ).
  • Liang F , ChenB . A review on biomedical applications of single-walled carbon nanotubes . Curr. Med. Chem.17 ( 1 ), 10 – 24 ( 2010 ).
  • Adeli M , SoleymanR , BeiranvandZ , MadaniF . Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions . Chem. Soc. Rev.42 ( 12 ), 5231 – 5256 ( 2013 ).
  • Graves EE , WeisslederR , NtziachristosV . Fluorescence molecular imaging of small animal tumor models . Curr. Mol. Med.4 ( 4 ), 419 – 430 ( 2004 ).
  • Jun YW , HuhYM , ChoiJSet al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging . J. Am. Chem. Soc.127 ( 16 ), 5732 – 5733 ( 2005 ).
  • Benaron DA . The future of cancer imaging . Cancer Metastasis Rev.21 ( 1 ), 45 – 78 ( 2002 ).
  • Czernin J , PhelpsME . Positron emission tomography scanning: current and future applications . Annu. Rev. Med.53 , 89 – 112 ( 2002 ).
  • Okarvi SM , JammazIA . Design, synthesis, radiolabeling and in vitro and in vivo characterization of tumor-antigen- and antibody-derived peptides for the detection of breast cancer . Anticancer Res.29 ( 4 ), 1399 – 1409 ( 2009 ).
  • Okarvi SM , JammazIA . Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents . Cancer Biother. Radiopharm.21 ( 1 ), 49 – 60 ( 2006 ).
  • Lee JH , HuhYM , JunYWet al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging . Nat. Med.13 ( 1 ), 95 – 99 ( 2007 ).
  • Al Faraj A , ShaikAS , Al SayedB . Preferential magnetic targeting of carbon nanotubes to cancer sites: noninvasive tracking using MRI in a murine breast cancer model . Nanomedicine (Lond.)10 ( 6 ), 931 – 948 ( 2015 ).
  • Cheng J , GuYJ , WangY , ChengSH , WongWT . Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos . Int. J. Nanomedicine6 , 2007 – 2021 ( 2011 ).
  • Ruggiero A , VillaCH , HollandJPet al. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes . Int. J. Nanomedicine5 , 783 – 802 ( 2010 ).
  • Sheridan C , KishimotoH , FuchsRKet al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis . Breast Cancer Res.8 ( 5 ), R59 ( 2006 ).
  • Al Faraj A , ShaikAP , ShaikAS . Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker . Int. J. Nanomedicine10 , 157 – 168 ( 2015 ).
  • Al Faraj A , Sultana ShaikA , PurezaMA , AlnafeaM , HalwaniR . Preferential macrophage recruitment and polarization in LPS-induced animal model for COPD: noninvasive tracking using MRI . PLoS ONE9 ( 3 ), e90829 ( 2014 ).
  • Economopoulou P , KaklamaniVG , SiziopikouK . The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies . Oncologist17 ( 11 ), 1394 – 1401 ( 2012 ).
  • Zhao Y , AlakhovaDY , KabanovAV . Can nanomedicines kill cancer stem cells?Adv. Drug Deliv. Rev.65 ( 13–14 ), 1763 – 1783 ( 2013 ).
  • Kostarelos K , BiancoA , PratoM . Promises, facts and challenges for carbon nanotubes in imaging and therapeutics . Nat. Nanotechnol.4 ( 10 ), 627 – 633 ( 2009 ).
  • Estanqueiro M , AmaralMH , ConceicaoJ , Sousa LoboJM . Nanotechnological carriers for cancer chemotherapy: the state of the art . Colloids Surf. B Biointerfaces126 , 631 – 648 ( 2015 ).
  • Louderbough JM , SchroederJA . Understanding the dual nature of CD44 in breast cancer progression . Mol. Cancer Res.9 ( 12 ), 1573 – 1586 ( 2011 ).
  • Gokmen-Polar Y , NakshatriH , BadveS . Biomarkers for breast cancer stem cells: the challenges ahead . Biomark. Med.5 ( 5 ), 661 – 671 ( 2011 ).
  • Gangopadhyay S , NandyA , HorP , MukhopadhyayA . Breast cancer stem cells: a novel therapeutic target . Clin. Breast Cancer13 ( 1 ), 7 – 15 ( 2013 ).
  • Battigelli A , Menard-MoyonC , Da RosT , PratoM , BiancoA . Endowing carbon nanotubes with biological and biomedical properties by chemical modifications . Adv. Drug Deliv. Rev.65 ( 15 ), 1899 – 1920 ( 2013 ).
  • Gong H , PengR , LiuZ . Carbon nanotubes for biomedical imaging: the recent advances . Adv. Drug Deliv. Rev.65 ( 15 ), 1951 – 1963 ( 2013 ).
  • Ali-Boucetta H , KostarelosK . Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation . Adv. Drug Deliv. Rev.65 ( 15 ), 2111 – 2119 ( 2013 ).
  • Sharma A , JainN , SareenR . Nanocarriers for diagnosis and targeting of breast cancer . BioMed Res. Int.2013 , 960821 ( 2013 ).
  • Liang S , LiC , ZhangCet al. CD44v6 monoclonal antibody-conjugated gold nanostars for targeted photoacoustic imaging and plasmonic photothermal therapy of gastric cancer stem-like cells . Theranostics5 ( 9 ), 970 – 984 ( 2015 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.